Finoriq research workspace
MCKESSON CORP (MCK) Company Overview
McKesson Corporation provides healthcare services in the United States and internationally. Review MCK filings, fundamentals, valuation, and ownership on Finoriq.
Company Snapshot
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Company
- MCKESSON CORP (MCK)
- Ticker
- MCK
- Market Cap
- $100.1B
- Latest Price
- $832.61
- Industry
- Other Pharmaceuticals
MCKESSON CORP (MCK) Current Valuation Metrics
Static valuation preview for MCKESSON CORP (MCK). Market data retrieved 2026-07-07. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 20.2x | Net Income | TTM FY 2026 |
| P/SMarket cap divided by latest TTM revenue. | 0.24x | Revenue | TTM FY 2026 |
| P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow. | 15.7x | Operating Cash Flow | TTM FY 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | 4.9% | Net Income | TTM FY 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | 6.4% | Operating Cash Flow | TTM FY 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.